PATENT CLAIM ANALYSIS

Application Number: 15939826
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "298000"]

Abstract:
The invention provides (+)-α-dihydrotetrabenazine succinate salt. Also provided are (+)-α-dihydrotetrabenazine succinate salt for use in medicine, pharmaceutical compositions comprising (+)-α-dihydrotetrabenazine succinate salt and a pharmaceutically acceptable excipient and the uses of (+)-α-dihydrotetrabenazine succinate salt as a VMAT2 receptor antagonist and in the treatment of a movement disorder such as Tourette's syndrome. The invention further provides a method for preparing the (+)-α-dihydrotetrabenazine succinate salt.

Claim (Index 9):
A method according to  claim 6 , wherein the treatment comprises administering to the subject a therapeutically effective amount of (+)-\u03b1-dihydrotetrabenazine succinate salt in an amount sufficient to achieve a blood plasma C max  concentration in the range from 3 ng/ml to 20 ng/ml and a C min  concentration of (+)-\u03b1-dihydrotetrabenazine in the range from 0.1 ng/ml to 10 ng/ml measured over a period of 3 hours following administration.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 90.0
- Lexical Diversity: 1.93023
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939837', '12555695', '15044655', '14030322', '15116786']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7751134518733972
- 35 USC 102 Novelty (BERT): 0.5828608600054137
- Combined Prediction Score: 0.7558881926865989
- Mean Citation Score: 303.2703160000001
- Max Citation Score: 531.46875
- Similarity Product: 386.8615667447448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test